earnings
RX
NASDAQ · RXRX
Recursion Pharmaceuticals, Inc. Class A Common Stock
Healthcare · Biotechnology
$3.31
Up+$0.02 (+0.61%)
Updated Aug 14, 2026, 3:51 AM
SID Score
4.3/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.83B
- P/E ratio
- -2.94
- Dividend yield
- 0.00%
- 52-week range
- $2.77 – $7.18
- Volume
- 10.7M
- Avg. volume
- 43.4M
Price performance
RXRX price history
1M range · 0 trading sessions · Daily adjusted prices
RXRX does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
Latest RXRX news
The latest Smart Investors Daily articles mentioning RXRX.
Stock researchResearch & News · Analysis
Loading stock research…